Hutasoit G, Miskad U, Akil F, Cangara M, Dahlan H, Yamin A
Asian Pac J Cancer Prev. 2024; 25(9):3143-3149.
PMID: 39342593
PMC: 11700324.
DOI: 10.31557/APJCP.2024.25.9.3143.
Goncharov A, Vashakidze N, Kharaishvili G
Biomedicines. 2024; 12(2).
PMID: 38398019
PMC: 10886988.
DOI: 10.3390/biomedicines12020418.
Pinheiro A, Petrucci G, Dourado A, Pires I
Animals (Basel). 2023; 13(21).
PMID: 37958147
PMC: 10648213.
DOI: 10.3390/ani13213392.
Akhurst R
Semin Cancer Biol. 2023; 96:100-114.
PMID: 37852342
PMC: 10883734.
DOI: 10.1016/j.semcancer.2023.10.003.
OConnell I, Dongre A
Mol Diagn Ther. 2023; 27(4):433-444.
PMID: 37193859
PMC: 10299941.
DOI: 10.1007/s40291-023-00652-3.
Prostate cancer metastasis and health disparities: a systematic review.
Liadi Y, Campbell T, Dike P, Harlemon M, Elliott B, Odero-Marah V
Prostate Cancer Prostatic Dis. 2023; 27(2):183-191.
PMID: 37046071
DOI: 10.1038/s41391-023-00667-1.
Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform.
Bunsick D, Matsukubo J, Szewczuk M
Cancers (Basel). 2023; 15(4).
PMID: 36831374
PMC: 9954791.
DOI: 10.3390/cancers15041030.
Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.
Huang Z, Zhang Z, Zhou C, Liu L, Huang C
MedComm (2020). 2022; 3(2):e144.
PMID: 35601657
PMC: 9115588.
DOI: 10.1002/mco2.144.
Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma.
Bottner J, Ribbat-Idel J, Klapper L, Jagomast T, Lemster A, Perner S
Int J Mol Sci. 2022; 23(9).
PMID: 35563463
PMC: 9100259.
DOI: 10.3390/ijms23095075.
Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression.
Elemam N, Imadeddin Malek A, Mahmoud E, El-Huneidi W, Talaat I
Biomedicines. 2022; 10(2).
PMID: 35203511
PMC: 8869528.
DOI: 10.3390/biomedicines10020301.
Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
Pai J, Chen X, Leu Y, Weng M
Int J Mol Sci. 2022; 23(3).
PMID: 35163593
PMC: 8835855.
DOI: 10.3390/ijms23031672.
A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma.
Feng S, Huang C, Guo L, Wang H, Liu H
Heliyon. 2022; 8(1):e08713.
PMID: 35036605
PMC: 8753132.
DOI: 10.1016/j.heliyon.2022.e08713.
Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks.
Uhan S, Hauptman N
Cells. 2022; 11(1).
PMID: 35011635
PMC: 8749983.
DOI: 10.3390/cells11010073.
Targeting lysine-specific demethylase 1A inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.
Zhang X, Li L, Yu C, Nath K, Zhuang S, Li X
FASEB J. 2021; 36(1):e22122.
PMID: 34958158
PMC: 9154004.
DOI: 10.1096/fj.202101566R.
Dual role of E-cadherin in cancer cells.
Rubtsova S, Zhitnyak I, Gloushankova N
Tissue Barriers. 2021; 10(4):2005420.
PMID: 34821540
PMC: 9621038.
DOI: 10.1080/21688370.2021.2005420.
Epithelial-mesenchymal transition and its transcription factors.
Debnath P, Huirem R, Dutta P, Palchaudhuri S
Biosci Rep. 2021; 42(1).
PMID: 34708244
PMC: 8703024.
DOI: 10.1042/BSR20211754.
Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer.
Khadri F, Issac M, Gaboury L
Cancers (Basel). 2021; 13(20).
PMID: 34680248
PMC: 8533811.
DOI: 10.3390/cancers13205099.
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
Block C, Mitchell A, Wu L, Glassbrook J, Craig D, Chen W
Oncogene. 2021; 40(46):6430-6442.
PMID: 34608266
PMC: 9421946.
DOI: 10.1038/s41388-021-02030-x.
Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells.
Arnouk H, Yum G, Shah D
Int J Mol Sci. 2021; 22(17).
PMID: 34502188
PMC: 8430685.
DOI: 10.3390/ijms22179280.
STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation.
Qiu Z, Dong B, Guo W, Piotr R, Longmore G, Yang X
Theranostics. 2021; 11(16):7658-7670.
PMID: 34335956
PMC: 8315073.
DOI: 10.7150/thno.62406.